)
Edge29 May 2026
Who You Gonna Call? The Story of Rollins
How Rollins built one of America's most consistent businesses through recurring pest control, trusted local brands, and decades of acquisitions.
Glycorex Transplantation
Glycorex Transplantation (GTAB) investor relations material
Glycorex Transplantation Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary22 May, 2026
Executive summary
Sales volume grew over 8% year-over-year, with increased units sold in Mexico, India, Canada, and Spain, and broader international reach.
Net sales declined 10% to SEK 8.7 million compared to Q1 2025, mainly due to lower sales in Germany after a strong prior-year quarter.
Operating income was SEK -3.4 million, and net income was SEK -3.5 million, both lower than the previous year.
Distribution markets, with lower average selling prices, accounted for a larger share of sales volume.
Carl-Magnus Högerkorp was appointed CEO, effective June 1, 2026.
Financial highlights
Net sales: SEK 8.7 million (down from SEK 9.7 million in Q1 2025).
Operating income: SEK -3.4 million (Q1 2025: SEK -1.5 million).
Net income: SEK -3.5 million (Q1 2025: SEK -1.7 million).
Earnings per share: SEK -0.04 (Q1 2025: SEK -0.02).
Cash and cash equivalents at period end: SEK 6.6 million (Q1 2025: SEK 13.5 million).
Equity: SEK 31.0 million (Q1 2025: SEK 40.6 million); equity/assets ratio: 65.0% (Q1 2025: 72.1%).
Outlook and guidance
Ongoing evaluation of international distribution and collaboration opportunities.
Continued focus on expanding in growth markets such as India, Mexico, and South Africa.
Regulatory approval and reimbursement inclusion targeted for US market entry.
R&D efforts ongoing in autoimmune disease treatment and universal blood products.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Glycorex Transplantation
- 10% revenue growth and improved margins, with strong market expansion and R&D focus.GTAB
Q4 202525 Feb 2026 - Q3 2025 saw 29% sales growth, improved margins, and new clinical and market breakthroughs.GTABQ3 202528 Nov 2025
- Sales up 11% in Q2 2025, losses halved, and liquidity strengthened by new share issue.GTABQ2 202529 Aug 2025
- Double-digit sales growth and improved results, with strategic expansion in key markets.GTABQ3 202413 Jun 2025
- Sales growth and improved results, but cash flow and liquidity risks persist.GTABQ2 202413 Jun 2025
- Double-digit sales growth and narrowed losses position Glycorex for global expansion.GTABQ4 20249 Jun 2025
- Strong sales growth and improved earnings, with expanded market presence and liquidity.GTABQ1 20256 Jun 2025
Next Glycorex Transplantation earnings date
Q2 202628 Aug, 2026
Glycorex Transplantation
Next Glycorex Transplantation earnings date
Q2 202628 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage